Live feed01:25:00·388dPRReleasevia QuantisnowSanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunologyByQuantisnow·Wall Street's wire, on your screen.BPMC· Blueprint Medicines CorporationSNY· SanofiHealth Care
